Caixa Research Consolidate – “Improving the treatment of AIS”

2021-10-26T07:30:03+00:00October 25th, 2021|News|

The support of CaixaResearch Consolidate, they will complete the development and clinical validation of BraiN20®, and from here, they will seek regulatory approval and begin commercialization.